Jabil Circuit Inc. (JBL) Pops 2.75% for January 26

Equities Staff |

One of the S&P 500’s big winners for Tuesday January 26 was Jabil Circuit Inc. (JBL) as the company’s stock climbed 2.75% to $19.44 on volume of 1.92 million shares.

The stock opened at $19.10 and saw an intraday low of $18.98 and an intraday high of $19.51. All told, the day saw a per-share gain of $0.52. The stock’s average daily volume of 3.13 million and 190.55 million shares outstanding. Jabil Circuit Inc. now has a 50-day SMA is $23.11 and 200-day SMA is $22.09, and it has a 52-week high of $26.00 and a 52-week low of $16.90.

Jabil Circuit Inc, together with its subsidiaries is a provider of electronic manufacturing services and solutions. It provides electronic design, production & product management services to companies in the aerospace & defense, automotive, among others.

Based out of St. Petersburg, FL, Jabil Circuit Inc. has 161,000 employees and, after today’s trading, reached a market cap of $3.7 billion. The stock’s P/E Ratio is 10.7. Its P/S ratio is 0.19, P/B ratio is 1.56, and P/FCF ratio is -16.6.

For a complete fundamental analysis analysis of Jabil Circuit Inc., check out Equities.com’s Stock Valuation Analysis report for JBL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…